Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Tufts University Boston · NIH-11197678 · Data updated 2026-11-12
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could eventually help patients like you get improved care and prevention options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00030-0-759302400002-1 |
| Project ID | NIH-11197678 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of infectious diseases or those with conditions that could be addressed by new medical countermeasures.
✕Less likely to help
Patients with established infectious diseases who are already receiving effective treatment may not benefit directly from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of various medical countermeasures before they are tested in humans. Patients may benefit from insights gained through this research, which could lead to improved therapies and preventive measures against infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments and preventive strategies for infectious diseases.
How similar studies have gone: Other research has shown success in developing pre-clinical models for infectious diseases, indicating that this approach is promising and has been tested in various contexts.
Where this research is happening
-
Tufts University Boston
Boston, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Diagnostics Core for Lyme disease testing and sample archiving
A centralized diagnostics core at a CLIA-certified lab provides standard Lyme disease tests and sample handling to support patient studies.
-
Clinical Coordination Core for Lyme disease and tickborne infections
A patient-facing core is coordinating care and enrollment for people with early Lyme disease and for antibody-based studies among groups at high risk of tick exposure.
-
Understanding why some people have ongoing symptoms after Lyme disease
A long-term study follows people diagnosed with acute Lyme disease to see who develops persistent symptoms and why, with care from a team of Lyme experts.
-
How bacteria talk to each other and what that means for infections
Researchers are studying how bacteria communicate and adapt in crowded environments like infections, with the goal of understanding what makes some bacteria more harmful or harder to treat.
-
Transdiagnostic therapy to improve mental health and TB treatment outcomes in India
A doctor-research team will test a flexible mental health therapy called CETA to help people with tuberculosis who also struggle with depression and unhealthy alcohol use, aiming to improve their TB treatment success.
-
Precision nutrition for personalized health in All of Us New England
A patient-focused program will study how different diets affect health in adults in the All of Us community, using real-world meals and controlled feeding sessions.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.